Search Results for "Alnylam"
Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.
More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.
For more information about our FDA-approved therapies, please see the Full Prescribing Information:
Vutrisiran: Orthostatic Hypotension
Standard response letter on the quantitative effect of vutrisiran on orthostatic hypotension in the HELIOS-A study, assessed using the postural blood pressure component of mNIS+7.
Standard response letter on the quantitative effect of vutrisiran on orthostatic hypotension in the HELIOS-A study, assessed using the postural blood pressure component of mNIS+7.
Patisiran: Use in Patients with hATTR Amyloidosis with Cardiomyopathy and Polyneuropathy
Standard response letter on the use of patisiran in patients with hATTR and mixed phenotype from the APOLLO-B study.
Standard response letter on the use of patisiran in patients with hATTR and mixed phenotype from the APOLLO-B study.
Vutrisiran: Mechanism of Action
Standard response letter on the mechanism of action of vutrisiran.
Standard response letter on the mechanism of action of vutrisiran.
Vutrisiran: Blood-Brain Barrier
Standard response letter containing pre-clinical data on the tissue distribution of vutrisiran.
Standard response letter containing pre-clinical data on the tissue distribution of vutrisiran.
Patisiran: Vitamin A Levels
Standard response letter on patisiran and vitamin A levels.
Standard response letter on patisiran and vitamin A levels.
Lumasiran: Kidney Related Outcomes
Standard response letter on lumasiran and kidney-related measures such as eGFR, kidney stone event rates, and nephrocalcinosis across clinical trials.
Standard response letter on lumasiran and kidney-related measures such as eGFR, kidney stone event rates, and nephrocalcinosis across clinical trials.
Lumasiran: Preparation and Administration
Standard response letter on the preparation and administration of lumasiran.
Standard response letter on the preparation and administration of lumasiran.
Patisiran: Management of Extravasation
Standard response letter on patisiran and management of extravasation. This medical information response contains information on extravasation prevention guidelines that were provided to patisiran clinical trial sites.
Standard response letter on patisiran and management of extravasation. This medical information response contains information on extravasation prevention guidelines that were provided to patisiran clinical trial sites.
